BRISPR^®

Bacteria platform to deliver RNA and protein

We have a strong preclinical pipeline fully owned and IP-protected. Our engineered bacteria deliver diverse cargos larger than other vehicles can handle, and are equipped with safety switches and other smart controls.

Disease areas

• Cancer

  • Lead asset RONC1 against pancreatic cancer

• Genetic diseases

  • Collaboration with large-cap pharma in progress